First Light Asset Management LLC lifted its position in shares of Teligent Inc (NASDAQ:TLGT) by 113.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,227,003 shares of the company’s stock after purchasing an additional 1,713,824 shares during the quarter. First Light Asset Management LLC owned 5.99% of Teligent worth $2,033,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently modified their holdings of TLGT. Spark Investment Management LLC grew its stake in shares of Teligent by 37.2% during the 1st quarter. Spark Investment Management LLC now owns 225,739 shares of the company’s stock worth $261,000 after purchasing an additional 61,239 shares during the period. Sanders Morris Harris LLC grew its stake in Teligent by 81.7% in the 2nd quarter. Sanders Morris Harris LLC now owns 3,814,012 shares of the company’s stock valued at $2,404,000 after acquiring an additional 1,715,239 shares during the period. State of New Jersey Common Pension Fund D acquired a new stake in Teligent in the 2nd quarter valued at $101,000. NJ State Employees Deferred Compensation Plan grew its stake in Teligent by 9.1% in the 2nd quarter. NJ State Employees Deferred Compensation Plan now owns 240,000 shares of the company’s stock valued at $151,000 after acquiring an additional 20,000 shares during the period. Finally, SG Americas Securities LLC acquired a new stake in Teligent in the 2nd quarter valued at $47,000. 55.31% of the stock is currently owned by institutional investors and hedge funds.
Teligent stock opened at $0.96 on Friday. The company’s fifty day moving average price is $0.81 and its 200 day moving average price is $0.86. Teligent Inc has a 1 year low of $0.42 and a 1 year high of $4.00. The stock has a market capitalization of $51.70 million, a P/E ratio of -2.91 and a beta of 1.29. The company has a debt-to-equity ratio of 23.23, a quick ratio of 0.86 and a current ratio of 1.61.
A number of research firms recently issued reports on TLGT. ValuEngine raised shares of Teligent from a “hold” rating to a “buy” rating in a research note on Wednesday, September 4th. Zacks Investment Research cut shares of Teligent from a “hold” rating to a “sell” rating in a research note on Tuesday.
Teligent Company Profile
Teligent, Inc, a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. It offers generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms.
Read More: Is a Roth IRA right for you?
Receive News & Ratings for Teligent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent and related companies with MarketBeat.com's FREE daily email newsletter.